• レポートコード:GIR-107A12037 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、109ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、アレルギー非薬理学的療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アレルギー非薬理学的療法の種類別市場規模(カプセル、錠剤、液体)、用途別市場規模(皮膚アレルギー、プエンアレルギー、粉じんアレルギー)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アレルギー非薬理学的療法の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Kirkland、GNC、Blackmores、Thompson's、BY-HEALTH、Healthy Care、Emerald Labs、FANCL Corporation、Zahler、VitaTree ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:カプセル、錠剤、液体 ・用途別分析2016年-2026年:皮膚アレルギー、プエンアレルギー、粉じんアレルギー ・アレルギー非薬理学的療法の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・アレルギー非薬理学的療法のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・アレルギー非薬理学的療法のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・アレルギー非薬理学的療法の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・アレルギー非薬理学的療法の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Allergy Non-pharmacologic Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Allergy Non-pharmacologic Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Allergy Non-pharmacologic Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Allergy Non-pharmacologic Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Capsule
Tablet
Liquid
Market segment by Application, can be divided into
Skin Allergy
Pouen Allergy
Dust Allergy
Market segment by players, this report covers
Kirkland
GNC
Blackmores
Thompson’s
BY-HEALTH
Healthy Care
Emerald Labs
FANCL Corporation
Zahler
VitaTree
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Allergy Non-pharmacologic Therapy
1.2 Classification of Allergy Non-pharmacologic Therapy by Type
1.2.1 Overview: Global Allergy Non-pharmacologic Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Allergy Non-pharmacologic Therapy Revenue Market Share by Type in 2020
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Liquid
1.3 Global Allergy Non-pharmacologic Therapy Market by Application
1.3.1 Overview: Global Allergy Non-pharmacologic Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Skin Allergy
1.3.3 Pouen Allergy
1.3.4 Dust Allergy
1.4 Global Allergy Non-pharmacologic Therapy Market Size & Forecast
1.5 Global Allergy Non-pharmacologic Therapy Market Size and Forecast by Region
1.5.1 Global Allergy Non-pharmacologic Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Allergy Non-pharmacologic Therapy Market Size by Region, (2016-2021)
1.5.3 North America Allergy Non-pharmacologic Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Allergy Non-pharmacologic Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Allergy Non-pharmacologic Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Allergy Non-pharmacologic Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Allergy Non-pharmacologic Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Allergy Non-pharmacologic Therapy Market Drivers
1.6.2 Allergy Non-pharmacologic Therapy Market Restraints
1.6.3 Allergy Non-pharmacologic Therapy Trends Analysis
2 Company Profiles
2.1 Kirkland
2.1.1 Kirkland Details
2.1.2 Kirkland Major Business
2.1.3 Kirkland Allergy Non-pharmacologic Therapy Product and Solutions
2.1.4 Kirkland Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Kirkland Recent Developments and Future Plans
2.2 GNC
2.2.1 GNC Details
2.2.2 GNC Major Business
2.2.3 GNC Allergy Non-pharmacologic Therapy Product and Solutions
2.2.4 GNC Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 GNC Recent Developments and Future Plans
2.3 Blackmores
2.3.1 Blackmores Details
2.3.2 Blackmores Major Business
2.3.3 Blackmores Allergy Non-pharmacologic Therapy Product and Solutions
2.3.4 Blackmores Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Blackmores Recent Developments and Future Plans
2.4 Thompson’s
2.4.1 Thompson’s Details
2.4.2 Thompson’s Major Business
2.4.3 Thompson’s Allergy Non-pharmacologic Therapy Product and Solutions
2.4.4 Thompson’s Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Thompson’s Recent Developments and Future Plans
2.5 BY-HEALTH
2.5.1 BY-HEALTH Details
2.5.2 BY-HEALTH Major Business
2.5.3 BY-HEALTH Allergy Non-pharmacologic Therapy Product and Solutions
2.5.4 BY-HEALTH Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BY-HEALTH Recent Developments and Future Plans
2.6 Healthy Care
2.6.1 Healthy Care Details
2.6.2 Healthy Care Major Business
2.6.3 Healthy Care Allergy Non-pharmacologic Therapy Product and Solutions
2.6.4 Healthy Care Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Healthy Care Recent Developments and Future Plans
2.7 Emerald Labs
2.7.1 Emerald Labs Details
2.7.2 Emerald Labs Major Business
2.7.3 Emerald Labs Allergy Non-pharmacologic Therapy Product and Solutions
2.7.4 Emerald Labs Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Emerald Labs Recent Developments and Future Plans
2.8 FANCL Corporation
2.8.1 FANCL Corporation Details
2.8.2 FANCL Corporation Major Business
2.8.3 FANCL Corporation Allergy Non-pharmacologic Therapy Product and Solutions
2.8.4 FANCL Corporation Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 FANCL Corporation Recent Developments and Future Plans
2.9 Zahler
2.9.1 Zahler Details
2.9.2 Zahler Major Business
2.9.3 Zahler Allergy Non-pharmacologic Therapy Product and Solutions
2.9.4 Zahler Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Zahler Recent Developments and Future Plans
2.10 VitaTree
2.10.1 VitaTree Details
2.10.2 VitaTree Major Business
2.10.3 VitaTree Allergy Non-pharmacologic Therapy Product and Solutions
2.10.4 VitaTree Allergy Non-pharmacologic Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 VitaTree Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Allergy Non-pharmacologic Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Allergy Non-pharmacologic Therapy Players Market Share
3.2.2 Top 10 Allergy Non-pharmacologic Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Allergy Non-pharmacologic Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Allergy Non-pharmacologic Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Allergy Non-pharmacologic Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Allergy Non-pharmacologic Therapy Revenue Market Share by Application (2016-2021)
5.2 Allergy Non-pharmacologic Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Allergy Non-pharmacologic Therapy Revenue by Type (2016-2026)
6.2 North America Allergy Non-pharmacologic Therapy Revenue by Application (2016-2026)
6.3 North America Allergy Non-pharmacologic Therapy Market Size by Country
6.3.1 North America Allergy Non-pharmacologic Therapy Revenue by Country (2016-2026)
6.3.2 United States Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Allergy Non-pharmacologic Therapy Revenue by Type (2016-2026)
7.2 Europe Allergy Non-pharmacologic Therapy Revenue by Application (2016-2026)
7.3 Europe Allergy Non-pharmacologic Therapy Market Size by Country
7.3.1 Europe Allergy Non-pharmacologic Therapy Revenue by Country (2016-2026)
7.3.2 Germany Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
7.3.3 France Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Allergy Non-pharmacologic Therapy Market Size by Region
8.3.1 Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Region (2016-2026)
8.3.2 China Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8.3.5 India Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Allergy Non-pharmacologic Therapy Revenue by Type (2016-2026)
9.2 South America Allergy Non-pharmacologic Therapy Revenue by Application (2016-2026)
9.3 South America Allergy Non-pharmacologic Therapy Market Size by Country
9.3.1 South America Allergy Non-pharmacologic Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Allergy Non-pharmacologic Therapy Market Size by Country
10.3.1 Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Allergy Non-pharmacologic Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Allergy Non-pharmacologic Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Allergy Non-pharmacologic Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Allergy Non-pharmacologic Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Allergy Non-pharmacologic Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Region (2021-2026)
Table 6. Kirkland Corporate Information, Head Office, and Major Competitors
Table 7. Kirkland Major Business
Table 8. Kirkland Allergy Non-pharmacologic Therapy Product and Solutions
Table 9. Kirkland Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. GNC Corporate Information, Head Office, and Major Competitors
Table 11. GNC Major Business
Table 12. GNC Allergy Non-pharmacologic Therapy Product and Solutions
Table 13. GNC Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Blackmores Corporate Information, Head Office, and Major Competitors
Table 15. Blackmores Major Business
Table 16. Blackmores Allergy Non-pharmacologic Therapy Product and Solutions
Table 17. Blackmores Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Thompson's Corporate Information, Head Office, and Major Competitors
Table 19. Thompson's Major Business
Table 20. Thompson's Allergy Non-pharmacologic Therapy Product and Solutions
Table 21. Thompson's Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BY-HEALTH Corporate Information, Head Office, and Major Competitors
Table 23. BY-HEALTH Major Business
Table 24. BY-HEALTH Allergy Non-pharmacologic Therapy Product and Solutions
Table 25. BY-HEALTH Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Healthy Care Corporate Information, Head Office, and Major Competitors
Table 27. Healthy Care Major Business
Table 28. Healthy Care Allergy Non-pharmacologic Therapy Product and Solutions
Table 29. Healthy Care Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Emerald Labs Corporate Information, Head Office, and Major Competitors
Table 31. Emerald Labs Major Business
Table 32. Emerald Labs Allergy Non-pharmacologic Therapy Product and Solutions
Table 33. Emerald Labs Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. FANCL Corporation Corporate Information, Head Office, and Major Competitors
Table 35. FANCL Corporation Major Business
Table 36. FANCL Corporation Allergy Non-pharmacologic Therapy Product and Solutions
Table 37. FANCL Corporation Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Zahler Corporate Information, Head Office, and Major Competitors
Table 39. Zahler Major Business
Table 40. Zahler Allergy Non-pharmacologic Therapy Product and Solutions
Table 41. Zahler Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. VitaTree Corporate Information, Head Office, and Major Competitors
Table 43. VitaTree Major Business
Table 44. VitaTree Allergy Non-pharmacologic Therapy Product and Solutions
Table 45. VitaTree Allergy Non-pharmacologic Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Allergy Non-pharmacologic Therapy Revenue (USD Million) by Players (2019-2021)
Table 47. Global Allergy Non-pharmacologic Therapy Revenue Share by Players (2019-2021)
Table 48. Breakdown of Allergy Non-pharmacologic Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Allergy Non-pharmacologic Therapy Players Head Office, Products and Services Provided
Table 50. Allergy Non-pharmacologic Therapy Mergers & Acquisitions in the Past Five Years
Table 51. Allergy Non-pharmacologic Therapy New Entrants and Expansion Plans
Table 52. Global Allergy Non-pharmacologic Therapy Revenue (USD Million) by Type (2016-2021)
Table 53. Global Allergy Non-pharmacologic Therapy Revenue Share by Type (2016-2021)
Table 54. Global Allergy Non-pharmacologic Therapy Revenue Forecast by Type (2021-2026)
Table 55. Global Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021)
Table 56. Global Allergy Non-pharmacologic Therapy Revenue Forecast by Application (2021-2026)
Table 57. North America Allergy Non-pharmacologic Therapy Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Allergy Non-pharmacologic Therapy Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Allergy Non-pharmacologic Therapy Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Allergy Non-pharmacologic Therapy Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Allergy Non-pharmacologic Therapy Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Allergy Non-pharmacologic Therapy Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Allergy Non-pharmacologic Therapy Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Allergy Non-pharmacologic Therapy Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Allergy Non-pharmacologic Therapy Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Allergy Non-pharmacologic Therapy Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Allergy Non-pharmacologic Therapy Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Allergy Non-pharmacologic Therapy Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Allergy Non-pharmacologic Therapy Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Allergy Non-pharmacologic Therapy Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Allergy Non-pharmacologic Therapy Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Allergy Non-pharmacologic Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Allergy Non-pharmacologic Therapy Picture
Figure 2. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Type in 2020
Figure 3. Capsule
Figure 4. Tablet
Figure 5. Liquid
Figure 6. Allergy Non-pharmacologic Therapy Revenue Market Share by Application in 2020
Figure 7. Skin Allergy Picture
Figure 8. Pouen Allergy Picture
Figure 9. Dust Allergy Picture
Figure 10. Global Allergy Non-pharmacologic Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Allergy Non-pharmacologic Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Region (2016-2026)
Figure 13. Global Allergy Non-pharmacologic Therapy Revenue Market Share by Region in 2020
Figure 14. North America Allergy Non-pharmacologic Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Allergy Non-pharmacologic Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Allergy Non-pharmacologic Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Allergy Non-pharmacologic Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Allergy Non-pharmacologic Therapy Market Drivers
Figure 20. Allergy Non-pharmacologic Therapy Market Restraints
Figure 21. Allergy Non-pharmacologic Therapy Market Trends
Figure 22. Kirkland Recent Developments and Future Plans
Figure 23. GNC Recent Developments and Future Plans
Figure 24. Blackmores Recent Developments and Future Plans
Figure 25. Thompson's Recent Developments and Future Plans
Figure 26. BY-HEALTH Recent Developments and Future Plans
Figure 27. Healthy Care Recent Developments and Future Plans
Figure 28. Emerald Labs Recent Developments and Future Plans
Figure 29. FANCL Corporation Recent Developments and Future Plans
Figure 30. Zahler Recent Developments and Future Plans
Figure 31. VitaTree Recent Developments and Future Plans
Figure 32. Global Allergy Non-pharmacologic Therapy Revenue Share by Players in 2020
Figure 33. Allergy Non-pharmacologic Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Allergy Non-pharmacologic Therapy Revenue Market Share in 2020
Figure 35. Global Top 10 Players Allergy Non-pharmacologic Therapy Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Allergy Non-pharmacologic Therapy Revenue Share by Type in 2020
Figure 38. Global Allergy Non-pharmacologic Therapy Market Share Forecast by Type (2021-2026)
Figure 39. Global Allergy Non-pharmacologic Therapy Revenue Share by Application in 2020
Figure 40. Global Allergy Non-pharmacologic Therapy Market Share Forecast by Application (2021-2026)
Figure 41. North America Allergy Non-pharmacologic Therapy Sales Market Share by Type (2016-2026)
Figure 42. North America Allergy Non-pharmacologic Therapy Sales Market Share by Application (2016-2026)
Figure 43. North America Allergy Non-pharmacologic Therapy Revenue Market Share by Country (2016-2026)
Figure 44. United States Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Allergy Non-pharmacologic Therapy Sales Market Share by Type (2016-2026)
Figure 48. Europe Allergy Non-pharmacologic Therapy Sales Market Share by Application (2016-2026)
Figure 49. Europe Allergy Non-pharmacologic Therapy Revenue Market Share by Country (2016-2026)
Figure 50. Germany Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Allergy Non-pharmacologic Therapy Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Allergy Non-pharmacologic Therapy Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Allergy Non-pharmacologic Therapy Revenue Market Share by Region (2016-2026)
Figure 58. China Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Allergy Non-pharmacologic Therapy Sales Market Share by Type (2016-2026)
Figure 65. South America Allergy Non-pharmacologic Therapy Sales Market Share by Application (2016-2026)
Figure 66. South America Allergy Non-pharmacologic Therapy Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Allergy Non-pharmacologic Therapy Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Allergy Non-pharmacologic Therapy Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Allergy Non-pharmacologic Therapy Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Allergy Non-pharmacologic Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source